Diagnosis of Infectious Diseases by CRISPR/Cas System
Mahintaj Dara(Shiraz University of Medical Sciences), S. M. M. Dastgheib, Seyed Ziaeddin Tabei, Mehdi Dianatpour(Shiraz University of Medical Sciences), Negin Shafieipour, Mahsa Saffar
Cited by 5
Related Papers
Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial
|Lipids in Health and Disease|2024|69
A comparative in vitro and in vivo study on bone tissue engineering potential of the collagen/nano-hydroxyapatite scaffolds loaded with ginger extract and curcumin
|Materials Today Communications|2022|40
Convergence of CRISPR and artificial intelligence: A paradigm shift in biotechnology
|Human Gene|2024|28
CRISPR/Cas as a Potential Diagnosis Technique for COVID-19.
|PubMed Central|2020|26